Vanda Pharmaceuticals (VNDA) Change in Account Payables (2010 - 2015)
Vanda Pharmaceuticals recorded quarterly Change in Account Payables of $142000.0 in Q2 2015, down 78.29% quarter-over-quarter from $654000.0 in Q1 2015, and up 120.14% year-over-year from $64503.9 in Q2 2014.
Vanda Pharmaceuticals' Change in Account Payables history runs 6 years deep, the most recent figure standing at $142000.0 for Q2 2015.
- In Q2 2015, Change in Account Payables rose 120.14% year-over-year to $142000.0; the TTM figure through Jun 2015 stood at $1.4 million (up 250.49% YoY), while the FY2014 annual figure was $174000.0, down 53.48% from the prior year.
- Change in Account Payables came in at $142000.0 for Q2 2015 at Vanda Pharmaceuticals, down from $654000.0 in the prior quarter.
- In the past five years, Change in Account Payables ranged from a high of $909000.0 in Q2 2012 to a low of -$803000.0 in Q4 2012.
- A 5-year average of $54611.1 and a median of $164000.0 in 2011 frame the typical range for Change in Account Payables.
- Across the five-year window, Change in Account Payables slumped 14875.0% in 2012 and surged 482.41% in 2013, its largest moves.
- Vanda Pharmaceuticals' Change in Account Payables stood at -$337000.0 in 2011, then tumbled by 138.28% to -$803000.0 in 2012, then jumped by 136.36% to $292000.0 in 2013, then fell by 1.37% to $288000.0 in 2014, then plunged by 50.69% to $142000.0 in 2015.
- According to Business Quant data, Change in Account Payables over the past three periods registered $142000.0, $654000.0, and $288000.0 for Q2 2015, Q1 2015, and Q4 2014 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -3.26 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 35.60 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Vanda Pharmaceuticals | 379.35 Mn | 177.04 Mn | 48.56 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2015 | 142,000.00 |
| Jun 30, 2015 | 142,000.00 |
| Mar 31, 2015 | 654,000.00 |
| Mar 31, 2015 | 654,000.00 |
| Dec 31, 2014 | 288,000.00 |
| Dec 31, 2014 | 288,000.00 |
| Sep 30, 2014 | 299,000.00 |
| Sep 30, 2014 | 299,000.00 |
| Jun 30, 2014 | -705,000.00 |
| Jun 30, 2014 | -705,000.00 |
| Mar 31, 2014 | 292,000.00 |
| Mar 31, 2014 | 292,000.00 |
| Dec 31, 2013 | 292,000.00 |
| Dec 31, 2013 | 292,000.00 |
| Sep 30, 2013 | -798,000.00 |
| Sep 30, 2013 | -798,000.00 |
| Jun 30, 2013 | 54,000.00 |
| Jun 30, 2013 | 54,000.00 |
| Mar 31, 2013 | 826,000.00 |
| Mar 31, 2013 | 826,000.00 |
| Dec 31, 2012 | -803,000.00 |
| Dec 31, 2012 | -803,000.00 |
| Sep 30, 2012 | -599,000.00 |
| Sep 30, 2012 | -599,000.00 |
| Jun 30, 2012 | 909,000.00 |
| Jun 30, 2012 | 909,000.00 |
| Mar 31, 2012 | -216,000.00 |
| Mar 31, 2012 | -216,000.00 |
| Dec 31, 2011 | -337,000.00 |
| Dec 31, 2011 | -337,000.00 |
| Sep 30, 2011 | -4,000.00 |
| Sep 30, 2011 | -4,000.00 |
| Jun 30, 2011 | 503,000.00 |
| Jun 30, 2011 | 503,000.00 |
| Mar 31, 2011 | 186,000.00 |
| Mar 31, 2011 | 186,000.00 |
| Dec 31, 2010 | 352,000.00 |
| Dec 31, 2010 | 352,000.00 |
| Sep 30, 2010 | -724,000.00 |
| Sep 30, 2010 | -724,000.00 |